Press Releases Year None2020201920182017201620152014 February 12, 2020 Castle Biosciences to Present at the 9th Annual SVB Leerink Global Healthcare Conference January 20, 2020 Castle Biosciences Announces Study Establishing the Value of Integrating DecisionDx-SCC Test into Management of High-Risk Cutaneous Squamous Cell Carcinoma January 9, 2020 Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2019 Performance Results, Delivering 29% DecisionDx-Melanoma Test Report Volume Growth in 2019
Press Releases Year None2020201920182017201620152014 February 12, 2020 Castle Biosciences to Present at the 9th Annual SVB Leerink Global Healthcare Conference January 20, 2020 Castle Biosciences Announces Study Establishing the Value of Integrating DecisionDx-SCC Test into Management of High-Risk Cutaneous Squamous Cell Carcinoma January 9, 2020 Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2019 Performance Results, Delivering 29% DecisionDx-Melanoma Test Report Volume Growth in 2019
February 12, 2020 Castle Biosciences to Present at the 9th Annual SVB Leerink Global Healthcare Conference
January 20, 2020 Castle Biosciences Announces Study Establishing the Value of Integrating DecisionDx-SCC Test into Management of High-Risk Cutaneous Squamous Cell Carcinoma
January 9, 2020 Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2019 Performance Results, Delivering 29% DecisionDx-Melanoma Test Report Volume Growth in 2019
